Stay updated on Cabiralizumab Combo in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page shows a system revision update: added Revision: v3.4.2 and removed Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:36:45.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 was removed from the Study Protocol/Statistical Analysis Plan section.
    Difference
    0.0%
    Check dated 2026-02-05T18:53:34.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.3.4 appears and v3.3.3 is removed. This is a minor metadata update that does not change the study details.
    Difference
    0.0%
    Check dated 2026-01-15T03:16:19.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The study record now includes a Locations section with multiple site locations (Arizona, California, Colorado, Florida, Maryland, Massachusetts, Missouri, New York, Pennsylvania, Tennessee, Texas, Washington, Alberta, Ontario, Chiba, Tokyo, Lanarkshire). The previous location listings were removed, and the revision is v3.3.3.
    Difference
    1%
    Check dated 2025-12-24T14:50:58.000Z thumbnail image
  6. Check
    91 days ago
    Change Detected
    Summary
    Revision: v3.3.2 has been added and Revision: v3.2.0 has been removed. This update pertains to versioning and does not modify any study data, eligibility criteria, or listed locations.
    Difference
    0.0%
    Check dated 2025-11-25T14:45:00.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    A government funding status notice banner was removed from the page, eliminating the warning about updates and operating status. The study details and main content remain unchanged.
    Difference
    0.2%
    Check dated 2025-11-18T07:28:58.000Z thumbnail image

Stay in the know with updates to Cabiralizumab Combo in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page.